tiprankstipranks
Advertisement
Advertisement

NGNE Stock Latest News

Neurogene Expands Leadership Team to Drive NGN-401 Commercialization
Company AnnouncementsNeurogene Expands Leadership Team to Drive NGN-401 Commercialization
8d ago
8K
NGNE
Neurogene appoints Christy Shafer as CCO
PremiumThe Fly
Neurogene appoints Christy Shafer as CCO
8d ago
NGNE
Compelling Risk‑Reward in Neurogene’s NGN-401: Differentiated Gene Therapy Approach in Rett Syndrome Supports Buy Rating
PremiumRatings
Compelling Risk‑Reward in Neurogene’s NGN-401: Differentiated Gene Therapy Approach in Rett Syndrome Supports Buy Rating
11d ago
NGNE
3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026
PremiumMarket News
3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026
19d ago
UPB
AIOT
Neurogene price target lowered to $180 from $200 at Canaccord
PremiumThe Fly
Neurogene price target lowered to $180 from $200 at Canaccord
22d ago
NGNE
Buy Rating Backed by Strong NGN-401 Clinical Progress, De-Risking Efficacy Data, and Solid Cash Runway in Rett Syndrome
PremiumRatingsBuy Rating Backed by Strong NGN-401 Clinical Progress, De-Risking Efficacy Data, and Solid Cash Runway in Rett Syndrome
1M ago
NGNE
Buy Rating Underpinned by De-Risked NGN‑401 Development, Aligned Manufacturing Strategy, and Cash Runway Through Key 2027–28 Catalysts
Premium
Ratings
Buy Rating Underpinned by De-Risked NGN‑401 Development, Aligned Manufacturing Strategy, and Cash Runway Through Key 2027–28 Catalysts
1M ago
NGNE
Neurogene Advances Rett Gene Therapy Toward BLA With Strong Cash Runway
Premium
Company Announcements
Neurogene Advances Rett Gene Therapy Toward BLA With Strong Cash Runway
1M ago
NGNE
1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts
PremiumMarket News
1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts
1M ago
NGNE
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
PremiumThe Fly
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
1M ago
EL
RL
Neurogene reports FY25 EPS ($4.24) vs ($4.28) last year
PremiumThe Fly
Neurogene reports FY25 EPS ($4.24) vs ($4.28) last year
1M ago
NGNE
NGNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NGNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
NGNE
Block upgraded, Duolingo downgraded: Wall Street’s top analyst calls
PremiumThe FlyBlock upgraded, Duolingo downgraded: Wall Street’s top analyst calls
2M ago
HON
LUV
Canaccord starts Neurogene with Buy rating, $200 price target
Premium
The Fly
Canaccord starts Neurogene with Buy rating, $200 price target
2M ago
NGNE
Neurogene initiated with a Buy at Canaccord
Premium
The Fly
Neurogene initiated with a Buy at Canaccord
2M ago
NGNE
Neurogene jumps 36% to $26.71 after Canaccord puts $200 target on shares
PremiumThe Fly
Neurogene jumps 36% to $26.71 after Canaccord puts $200 target on shares
2M ago
NGNE
Neurogene Gains FDA Breakthrough Status for Rett Gene Therapy
PremiumCompany Announcements
Neurogene Gains FDA Breakthrough Status for Rett Gene Therapy
2M ago
8K
NGNE
Neurogene announces Treakthrough Therapy Designation for NGN-401
PremiumThe Fly
Neurogene announces Treakthrough Therapy Designation for NGN-401
2M ago
NGNE
Neurogene initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Neurogene initiated with an Outperform at LifeSci Capital
3M ago
NGNE
Neurogene outlines 2026 milestones for NGN-401 Rett therapy
PremiumCompany AnnouncementsNeurogene outlines 2026 milestones for NGN-401 Rett therapy
4M ago
8K
NGNE
Short Report: Vera Therapeutics bears retreat as stock rallies
Premium
The Fly
Short Report: Vera Therapeutics bears retreat as stock rallies
4M ago
MBLY
MDGL
Neurogene Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Neurogene Inc. Reports Q3 2025 Financial Results
5M ago
NGNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >